Max Masucci Analyst Performance

Analyst at Roth Mkm

Max Masucci is a stock analyst at Roth Mkm in the medical sector, covering 9 publicly traded companies. Over the past year, Max Masucci has issued 3 stock ratings, including and buy recommendations. While full access to Max Masucci's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Max Masucci's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
18 Last 6 Years
Buy Recommendations
94.44% 17 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy94.4%17 ratings
Hold5.6%1 ratings
Sell0.0%0 ratings

Out of 18 total stock ratings issued by Max Masucci at Roth Mkm, the majority (94.4%) have been Buy recommendations, followed by 5.6% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
9 companies

Max Masucci, an analyst at Roth Mkm, currently covers 9 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
9 companies
100.0%

Max Masucci of Roth Mkm specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
4 companies
44.4%
MEDICAL SERVICES
2 companies
22.2%
MED PRODUCTS
1 company
11.1%
ANALYTICAL INSTRUMENTS
1 company
11.1%
SURGICAL & MEDICAL INSTRUMENTS
1 company
11.1%

Max Masucci's Ratings History at Roth Mkm

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biodesix, Inc. stock logo
BDSX
Biodesix
6/24/2026Initiated Coverage$18.67$32.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
6/24/2026Initiated Coverage$22.12$40.00Buy
Exagen Inc. stock logo
XGN
Exagen
6/24/2026Initiated Coverage$4.52$8.00Buy